We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Top Sells

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10.9M
2
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$7.99M
3
ORPH
Orphazyme A/S
ORPH
+$5.06M
4
BBIO icon
BridgeBio Pharma
BBIO
+$3.35M
5
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
+$3.25M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.02%
3 Healthcare 14.17%
4 Industrials 13.83%
5 Financials 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XELA
1101
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$98K 0.02%
+20
New +$94.5K
ZVO
1102
DELISTED
Zovio Inc. Common Stock
ZVO
$97K 0.02%
+20,415
New +$83.9K
ABUS icon
1103
Arbutus Biopharma
ABUS
$915M
$93K 0.02%
+26,221
New +$91.8K
CLPR
1104
Clipper Realty
CLPR
$46.2M
$93K 0.02%
13,239
+3,181
+32% +$19.7K
MFA
1105
MFA Financial
MFA
$933M
$91K 0.01%
5,828
-2,322
-28% -$31.3K
RNTX
1106
Rein Therapeutics
RNTX
$69.9M
$90K 0.01%
+4,328
New +$108K
ALTO icon
1107
Alto Ingredients
ALTO
$340M
$89K 0.01%
+16,419
New +$114K
AMBR
1108
Amber International Holding Ltd
AMBR
$130M
$89K 0.01%
1,038
-86
-8% -$6.61K
ADXS
1109
DELISTED
Advaxis Inc
ADXS
$88K 0.01%
253,775
+217,634
+602% +$80.7K
CIG icon
1110
CEMIG Preferred Shares
CIG
$6.01B
$87K 0.01%
+56,906
New +$69.2K
GGB icon
1111
Gerdau
GGB
$9.7B
$85K 0.01%
+22,932
New +$76.4K
ACHV icon
1112
Achieve Life Sciences
ACHV
$683M
$82K 0.01%
10,129
-14,861
-59% -$126K
BIOL
1113
DELISTED
Biolase, Inc.
BIOL
$82K 0.01%
+78
New +$59.5K
CMO
1114
DELISTED
Capstead Mortgage Corp.
CMO
$82K 0.01%
14,139
-70,946
-83% -$405K
REI icon
1115
Ring Energy
REI
$339M
$81K 0.01%
122,615
-167,456
-58% -$110K
GYRE icon
1116
Gyre Therapeutics
GYRE
$744M
$80K 0.01%
+1,685
New +$73K
TELL
1117
DELISTED
Tellurian Inc.
TELL
$80K 0.01%
+62,380
New +$70.6K
BCRX icon
1118
BioCryst Pharmaceuticals
BCRX
$2.4B
$78K 0.01%
+10,500
New +$54.1K
XNET
1119
Xunlei
XNET
$326M
$77K 0.01%
+26,581
New +$77.7K
GOGL
1120
DELISTED
Golden Ocean Group
GOGL
$75K 0.01%
+16,158
New +$64.8K
DYAI icon
1121
Dyadic International
DYAI
$36.4M
$74K 0.01%
13,823
-20,464
-60% -$135K
FBIO icon
1122
Fortress Biotech
FBIO
$88.7M
$73K 0.01%
+1,529
New +$66.2K
CYCN icon
1123
Cyclerion Therapeutics
CYCN
$16.7M
$71K 0.01%
+1,167
New +$79.6K
KALA icon
1124
KALA BIO
KALA
$14.5M
$71K 0.01%
+4
New +$75.3K
CALA
1125
DELISTED
Calithera Biosciences, Inc
CALA
$71K 0.01%
723
-7,042
-91% -$617K
43 44
45
46 47

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.